Page last updated: 2024-10-28

lidocaine and Neurodegenerative Diseases

lidocaine has been researched along with Neurodegenerative Diseases in 1 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.

Research Excerpts

ExcerptRelevanceReference
"The BFM dystonia scale score was initially 16 and improved to 12 on both immediate post-treatment and eight-week follow-up."5.35Clinical improvement of secondary focal limb dystonia in neurodegenerative disease following a five-day lidocaine infusion: a case report. ( Irwin, D; Lippa, CF; Revuelta, G, 2009)
"The BFM dystonia scale score was initially 16 and improved to 12 on both immediate post-treatment and eight-week follow-up."1.35Clinical improvement of secondary focal limb dystonia in neurodegenerative disease following a five-day lidocaine infusion: a case report. ( Irwin, D; Lippa, CF; Revuelta, G, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Irwin, D1
Revuelta, G1
Lippa, CF1

Other Studies

1 other study available for lidocaine and Neurodegenerative Diseases

ArticleYear
Clinical improvement of secondary focal limb dystonia in neurodegenerative disease following a five-day lidocaine infusion: a case report.
    Journal of the neurological sciences, 2009, Feb-15, Volume: 277, Issue:1-2

    Topics: Anesthetics, Local; Dystonia; Dystonic Disorders; Humans; Lidocaine; Male; Middle Aged; Neurodegener

2009